FDA Purple Book · Reference family
Ziv-Aflibercept (Zaltrap)
Ziv-Aflibercept is an FDA-licensed reference biologic from Sanofi-Aventis U.S. LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2012
Reference approved
Reference product
351(a)BLA 125418
Zaltrap Ziv-Aflibercept
Sanofi-Aventis U.S. LLC
- Approved
- Aug 03, 2012
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Ziv-Aflibercept, in chronological order.
Reference approval
Approval date of the reference Ziv-Aflibercept product.
14 yr ago
Frequently asked questions
Are there biosimilars approved for Ziv-Aflibercept (Zaltrap)?
No 351(k) biosimilars or interchangeable biosimilars referencing Ziv-Aflibercept are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.